OSCR

Computationally guided discovery of Ly6e/LY6E-dependent AAV capsid variants.

Overview

Authors: Hiroaki Ono1, Shoko Fujino1, Genshiro A Sunagawa1,2
  1. Laboratory for Hibernation Biology, RIKEN Center for Biosystems Dynamics Research (BDR), Hyogo 651-0092, Japan
  2. Suntory Rising Stars Encouragement Program in Life Sciences (SunRiSE) Fellow, Suntory Foundation for Life Sciences, Kyoto 619-0284, Japan
Journal: iScience, volume 29, issue 5, article 115554
Dates: received 24 November 2025; accepted 27 March 2026; published online 1 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1016/j.isci.2026.115554 · PMID 42028008 · PMCID PMC13101293 · OpenAlex W7147546213
Open access: gold, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: cellular / molecular (subfield)
Methods: Spectral & time-frequency, Statistics
Keywords: Drug delivery system, Neuroscience, Genetic engineering
Topic: Virus-based gene therapy research (Genetics, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: Suntory Foundation for Life Sciences; Japan Society for the Promotion of Science (23H04941, 23K14130); RIKEN
Citations: not cited yet (Europe PMC); 74 references in the paper

Abstract

Systemic adeno-associated virus (AAV) delivery to the central nervous system (CNS) would broaden neuroscience studies and therapeutic development, but capsids evolved in mice often underperform across species. We used structure-guided computational prioritization of short peptide inserts predicted to engage the BBB-associated Ly6-family receptor Ly6e/LY6E, grafting candidates into a surface loop of an AAV9 capsid. Selected variants increased blood-brain barrier transduction and enabled widespread CNS gene delivery in Syrian hamsters after intravenous dosing, with lead capsids showing Ly6e-dependent binding and transduction in cell assays. Using the same strategy for the human ortholog, we identified multiple AAV9 variants with LY6E-dependent enhancement of in vitro transduction. These capsids support species-matched CNS delivery and demonstrate how receptor-informed computation can focus experimental screening when in vivo library selection is impractical.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

Datasets cited

Data and code availability

Peptide sequence data generated in this study are provided in the figures. Publicly available datasets used in this study include UniProt protein sequence records for mouse Ly6A (UniProt: P05533 (https://www.uniprot.org/uniprotkb/https://www.uniprot.org/P05533)), Syrian hamster Ly6e (UniProt: A0A1U7Q6V5) and human LY6E (UniProt: Q16553 (https://www.uniprot.org/uniprotkb/https://www.uniprot.org/Q16553)), as well as human brain expression data from the Human Protein Atlas (genes analyzed: LY6E, TFRC, and SLC2A1; https://www.proteinatlas.org/humanproteome/brain). Structural model files generated in this study and image data underlying the figures are available from the lead contact upon reasonable request.

Custom Python code used for analysis has been deposited in Mendeley Data and is publicly available as of the date of publication at https://doi.org/10.17632/g49ycssrnv.1.

Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request. Plasmids generated in this study are available from Addgene as listed in the key resources table.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Hiroaki Ono (0000-0002-4987-6797); removed Hiroaki Ono

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 3 authors, 3 keywords, 3 funders, 74 references.

Cite

This paper

Ono, H., Fujino, S., & Sunagawa, G. A. (2026). Computationally guided discovery of Ly6e/LY6E-dependent AAV capsid variants. iScience, 29(5), 115554. https://doi.org/10.1016/j.isci.2026.115554

BibTeX

@article{ono2026computationally,
author = {Ono, Hiroaki and Fujino, Shoko and Sunagawa, Genshiro A},
title = {{Computationally guided discovery of Ly6e/LY6E-dependent AAV capsid variants}},
journal = {iScience},
year = {2026},
month = apr,
volume = {29},
number = {5},
pages = {115554},
publisher = {Elsevier},
issn = {2589-0042},
doi = {10.1016/j.isci.2026.115554},
url = {https://doi.org/10.1016/j.isci.2026.115554},
pmid = {42028008},
pmcid = {PMC13101293}
}

RIS

TY - JOUR
AU - Ono, Hiroaki
AU - Fujino, Shoko
AU - Sunagawa, Genshiro A
TI - Computationally guided discovery of Ly6e/LY6E-dependent AAV capsid variants
T2 - iScience
J2 - iScience
PY - 2026
DA - 2026/04/01
VL - 29
IS - 5
SP - 115554
SN - 2589-0042
PB - Elsevier
DO - 10.1016/j.isci.2026.115554
UR - https://doi.org/10.1016/j.isci.2026.115554
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.isci.2026.115554",
"type": "article-journal",
"title": "Computationally guided discovery of Ly6e/LY6E-dependent AAV capsid variants",
"container-title": "iScience",
"author": [
{
"family": "Ono",
"given": "Hiroaki"
},
{
"family": "Fujino",
"given": "Shoko"
},
{
"family": "Sunagawa",
"given": "Genshiro A"
}
],
"container-title-short": "iScience",
"volume": "29",
"issue": "5",
"page": "115554",
"DOI": "10.1016/j.isci.2026.115554",
"PMID": "42028008",
"PMCID": "PMC13101293",
"ISSN": "2589-0042",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.isci.2026.115554",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1126/sciadv.adg6618 [code]
Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors.
Journal: Science advances
In common: cellular / molecular, 20 references
[2] doi:10.1016/j.celrep.2025.116419 [code]
AAVs targeting human carbonic anhydrase IV enhance gene delivery to the brain.
Journal: Cell reports
In common: cellular / molecular, 18 references
[3] doi:10.1038/s41467-024-52149-0 [code]
Human cell surface-AAV interactomes identify LRP6 as blood-brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder.
Journal: Nature communications
In common: cellular / molecular, 15 references
[4] doi:10.3389/fimmu.2021.730825 [code]
Deep Parallel Characterization of AAV Tropism and AAV-Mediated Transcriptional Changes <i>via</i> Single-Cell RNA Sequencing.
Journal: Frontiers in immunology
In common: cellular / molecular, 12 references
[5] doi:10.1371/journal.pbio.3002112 [code]
Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier.
Journal: PLoS biology
In common: cellular / molecular, 11 references
[6] doi:10.1016/j.medj.2022.11.002 [code]
Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS.
Journal: Med (New York, N.Y.)
In common: 11 references
[7] doi:10.1038/s41565-023-01419-x [code]
Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain.
Journal: Nature nanotechnology
In common: cellular / molecular, 11 references
[8] doi:10.1016/j.omta.2026.201693
Spatial mapping of barcoded, brain-tropic AAVs using multiplexed RNA <i>in situ</i> hybridization.
Journal: Molecular therapy. Advances
In common: cellular / molecular, 10 references
[9] doi:10.1038/s41587-025-02565-4
Spatial genomics of AAV vectors reveals mechanism of transcriptional crosstalk that enables targeted delivery of large genetic cargo.
Journal: Nature biotechnology
In common: cellular / molecular, 10 references
[10] doi:10.1016/j.ymthe.2026.03.030 [code]
Structural basis of liver de-targeting and neuronal tropism of CNS-targeted AAV capsids.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
In common: cellular / molecular, 10 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.